Does Nattokinase Lower Cholesterol? Here’s the Evidence

Nattokinase has gained attention as a natural compound with powerful cardiovascular benefits, particularly for its ability to support circulation and break down fibrin. As interest grows, many people are asking whether these benefits extend to cholesterol management. 

The question is straightforward, but the answer requires a deeper understanding of how cholesterol behaves inside the body and what actually drives arterial buildup.

What Is Nattokinase and How Does It Work?

Nattokinase is an enzyme derived from natto, a traditional Japanese fermented soybean food consumed for centuries. It is produced during the fermentation process by Bacillus subtilis and is known for its potent fibrinolytic activity. This means it helps break down fibrin, a protein involved in blood clot formation and arterial plaque structure.

Its primary function is not to alter cholesterol production but to improve the internal environment of blood vessels. 

By dissolving excess fibrin, nattokinase helps maintain smoother blood flow and reduces the structural components that contribute to plaque formation. This is a key distinction that separates it from pharmaceutical approaches like statins.

Another important mechanism is its effect on circulation and blood viscosity. Thicker blood and reduced flow can accelerate the accumulation of lipids along arterial walls. 

By improving circulation, nattokinase indirectly supports better lipid transport and vascular function. This creates conditions that are less favorable for cholesterol buildup over time.

Does Nattokinase Lower Cholesterol Directly?

Nattokinase is not primarily a cholesterol-lowering compound in the same way as statins or other lipid-lowering medications. 

It does not directly inhibit cholesterol synthesis in the liver, nor does it specifically target LDL receptors to reduce circulating cholesterol levels. This distinction is important for setting realistic expectations.

Some studies have reported modest improvements in lipid profiles, including reductions in LDL cholesterol and triglycerides alongside increases in HDL cholesterol. However, these outcomes are not consistent across all research and are generally considered secondary effects rather than the primary mechanism of action.

The more accurate interpretation is that nattokinase may contribute to improved cholesterol balance indirectly. By enhancing blood flow, reducing fibrin accumulation, and supporting arterial health, it creates an environment where cholesterol is less likely to become trapped or oxidized within vessel walls.

This indirect effect is often misunderstood. People expect a direct drop in cholesterol numbers, but nattokinase works at a deeper level by addressing the conditions that lead to cholesterol-related problems. This makes it more aligned with long-term vascular health rather than short-term numerical changes.

The Indirect Link Between Nattokinase and Cholesterol

Cholesterol accumulation does not occur randomly. It is typically a response to damage within the arterial wall. When inflammation or stress weakens the vessel lining, the body initiates a repair process that involves:

• Cholesterol

• Calcium

• Fibrin

Over time, this process can lead to plaque formation.

Nattokinase targets a critical component of this process: fibrin. Fibrin acts like a mesh that traps cholesterol particles and stabilizes plaque deposits. By breaking down fibrin, nattokinase helps disrupt this structure and may assist in gradually reducing buildup within the arteries.

This relationship explains why nattokinase is often associated with improved cardiovascular outcomes without being a direct cholesterol-lowering agent. Its impact lies in modifying the environment where cholesterol operates.

Key Ways Nattokinase Influences Cholesterol Dynamics

• Reduces fibrin accumulation that traps LDL cholesterol

• Helps release cholesterol deposits embedded in arterial walls

• Improves arterial flexibility and elasticity

• Enhances circulation, supporting more efficient lipid transport

Healthletic’s Nattokinase is formulated to support these mechanisms at a higher potency level, aiming to address not just circulating cholesterol but the structural conditions that allow it to accumulate.

What Research Says About Nattokinase and Cholesterol

Scientific research on nattokinase presents a nuanced picture. 

While it is well-established for its fibrinolytic and blood pressure–lowering effects, its role in cholesterol management is still being explored. Some clinical studies have shown improvements in lipid profiles, particularly when nattokinase is used consistently over several months.

These improvements often include reductions in LDL cholesterol and triglycerides, along with modest increases in HDL cholesterol. However, these findings are not universal, and the degree of change tends to be less pronounced than what is seen with pharmaceutical interventions.

Stronger evidence exists for nattokinase’s impact on;

• Circulation

• Blood viscosity

• Arterial health

These factors are closely linked to how cholesterol behaves in the body, even if they do not directly change cholesterol production. 

Improved circulation reduces the likelihood of lipid stagnation, while better arterial function decreases the chances of cholesterol becoming embedded in vessel walls.

The overall takeaway from research is that nattokinase supports cardiovascular health in a broader sense. Its effects on cholesterol are part of a larger network of benefits rather than a standalone outcome. 

This makes it particularly valuable as part of a comprehensive strategy rather than a single-purpose solution.

Can Nattokinase Help Reduce Plaque and “Bad” Cholesterol Buildup?

Arterial plaque is a complex structure composed of:

• Cholesterol

• Fibrin

• Calcium

• Cellular debris

While cholesterol often receives the most attention, fibrin plays a critical role in holding these components together and stabilizing the plaque. This is where nattokinase becomes particularly relevant.

By breaking down fibrin, nattokinase may help weaken the structural integrity of plaque deposits. Over time, this process can support gradual reductions in plaque burden, especially when combined with healthy lifestyle habits. 

This does not happen instantly, but consistent use may contribute to meaningful changes in arterial health.

It is also important to distinguish between circulating cholesterol and cholesterol embedded in plaque. Nattokinase does not directly lower cholesterol levels in the bloodstream in a dramatic way, but it may help address the cholesterol that has already become trapped within arterial walls.

Why Arterial Inflammation Matters More Than Cholesterol Alone

Cholesterol is often viewed as the primary cause of cardiovascular disease, but it is more accurately a participant in a larger process. 

Arterial inflammation is the underlying factor that initiates and drives plaque formation. Without inflammation, cholesterol is less likely to accumulate in harmful ways.

The process typically follows a predictable sequence:

1. Arterial damage occurs due to factors like stress, poor diet, or aging

2. Inflammation develops, weakening the vessel lining

3. Cholesterol and other particles accumulate at the damaged site

4. Fibrin is deposited, forming a mesh that traps these materials

5. Plaque forms and hardens, restricting blood flow

Nattokinase intervenes at the fibrin stage, which is a critical turning point in this process. By breaking down fibrin, it helps prevent the stabilization and growth of plaque. This makes it a valuable tool for addressing the root cause rather than just the symptom.

This perspective shifts the focus from simply lowering cholesterol numbers to improving overall arterial health. It aligns with a more comprehensive approach to cardiovascular wellness, where multiple factors are addressed simultaneously.

Who Should Consider Nattokinase for Cholesterol Support

Nattokinase is best suited for individuals who want to take a broader, more structural approach to cardiovascular health. Rather than focusing only on lowering cholesterol numbers, it supports the underlying factors that influence how cholesterol behaves in the body—particularly circulation, fibrin buildup, and arterial function.

People who may benefit from nattokinase include:

• Individuals with borderline or elevated LDL cholesterol: Those who are not yet on medication or are looking for additional support may benefit from nattokinase’s indirect effects on cholesterol dynamics.

• People with poor circulation or sluggish blood flow: Reduced circulation can contribute to cholesterol accumulation, and improving blood flow may help support better vascular health.

• Those with elevated blood pressure: Since blood pressure and arterial stiffness are closely linked to plaque development, nattokinase may offer supportive benefits in this area.

• Individuals concerned about arterial plaque buildup: Nattokinase’s ability to break down fibrin makes it relevant for those focused on preventing or managing long-term plaque accumulation.

• Adults focused on preventive cardiovascular care: Even without diagnosed issues, individuals looking to maintain healthy arteries as they age may benefit from consistent use.

• People already following a heart-healthy lifestyle: Those who prioritize diet, exercise, and hydration can use nattokinase as an additional layer of support for vascular function.

Nattokinase is not intended to replace prescribed treatments for serious cholesterol conditions. Instead, it works best as part of a comprehensive strategy that includes:

• Medical guidance

• Lifestyle improvements

• Targeted supplementation

Incorporating a high-quality option like Healthletic’s Nattokinase can help reinforce these efforts by supporting circulation and arterial health over time.

Final Verdict: Does Nattokinase Lower Cholesterol?

Nattokinase is not a direct cholesterol-lowering compound, but it plays a meaningful role in supporting cardiovascular health. Its primary strength lies in addressing fibrin buildup, improving circulation, and helping maintain flexible, healthy arteries. These effects influence how cholesterol behaves within the body rather than simply reducing its production.

This distinction is important for understanding its value. Nattokinase works at the structural level, targeting the conditions that allow cholesterol to accumulate and form plaque. When used consistently as part of a broader health strategy, it can contribute to improved vascular function and long-term cardiovascular support.

Take the Next Step Toward Better Arterial Health

Cholesterol alone is not the full story. Arterial inflammation and fibrin buildup are key drivers of cardiovascular risk, and addressing these factors can lead to more meaningful improvements in overall health.

Healthletic’s Nattokinase is designed to support this deeper approach, delivering a clinically relevant dose that targets fibrin and promotes healthy circulation. With consistent use and the right lifestyle habits, it offers a practical way to support long-term arterial health and reduce the conditions that contribute to cholesterol-related issues.

A comprehensive strategy always delivers better results than focusing on a single number. Supporting the structure and function of your arteries is a powerful step toward lasting cardiovascular wellness.

Frequently Asked Questions

Does nattokinase lower cholesterol levels?

Nattokinase does not directly lower cholesterol in the same way as medications like statins. Its primary role is to break down fibrin and support circulation, which can indirectly improve how cholesterol behaves within the body over time.

Can nattokinase replace statins?

Nattokinase should not replace prescribed medications. It is best used as a complementary approach that supports arterial health alongside other treatments.

Is nattokinase good for high LDL?

Nattokinase can support the underlying factors that contribute to LDL-related issues, particularly arterial inflammation and fibrin buildup. However, it is not a direct LDL-lowering agent.

Can nattokinase remove plaque?

Nattokinase may help break down the fibrin component of plaque, which can support gradual reductions in buildup over time when combined with healthy lifestyle practices.

References

• Chen, H., McGowan, E. M., Ren, N., Lal, S., Nassif, N., Shad-Kaneez, F., ... & Lin, Y. (2018). Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases. Biomarker insights, 13, 1177271918785130. Link.

• Wei, C., Cai, R., Song, Y., Liu, X., & Xu, H. L. (2025). Research progress of nattokinase in reducing blood lipid. Nutrients, 17(11), 1784. Link.